[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f-IiH4ABlgfUOAkpEDTbIVv_hkV5VkZAtraW9uirIqIA":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":9,"nonDrugCount":11,"topConditions":12,"upcomingReadouts":34,"phaseBuckets":40,"rows":47},"Universidade Federal do Rio Grande do Norte",[4],84,false,6,1,3754,77,[13,16,19,21,24,27,29,31],{"name":14,"count":15},"Low Back Pain",9,{"name":17,"count":18},"Stroke",5,{"name":20,"count":18},"Asthma",{"name":22,"count":23},"Transcranial Direct Current Stimulation",4,{"name":25,"count":26},"Mucositis",3,{"name":28,"count":26},"Neuromuscular Performance and Balance",{"name":30,"count":26},"Patellofemoral Pain Syndrome",{"name":32,"count":33},"Shoulder Pain",2,[35],{"nctId":36,"briefTitle":37,"date":38,"intervention":39},"NCT07562191","Inhaled DMT for Major Depressive Disorder","2027-02-01","N,N-Dimethyltryptamine",[41,42,43,44,45,46],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[48,100,132,156],{"intervention":39,"totalTrials":26,"cells":49},{"EARLY_PHASE1":50,"PHASE1":53,"PHASE2":67,"PHASE3":94,"PHASE4":96,"NA":98},{"trials":51,"activeCount":52},[],0,{"trials":54,"activeCount":52},[55],{"nctId":56,"briefTitle":57,"status":58,"phases":59,"primaryCompletion":60,"completion":60,"start":61,"enrollment":62,"conditions":63,"interventions":66},"NCT05901012","Safety and Tolerability of DMT in Healthy Adults","COMPLETED",[42],"2023-07-17","2023-04-26",25,[64,65],"Safety Issues","Healthy Volunteers",[39],{"trials":68,"activeCount":9,"soonestReadout":38},[69,82],{"nctId":36,"briefTitle":37,"status":70,"phases":71,"primaryCompletion":38,"completion":72,"start":73,"enrollment":74,"conditions":75,"interventions":81},"RECRUITING",[43],"2027-08-01","2026-08-01",140,[76,77,78,79,80],"MDD","Major Depressive Disorder (MDD)","Major Depression","Suicidal Ideation","Suicide",[39,39],{"nctId":83,"briefTitle":84,"status":58,"phases":85,"primaryCompletion":86,"completion":87,"start":88,"enrollment":89,"conditions":90,"interventions":93},"NCT06094907","Safety, Tolerability and Antidepressant Effects of DMT in Patients With Depression",[43],"2024-01-15","2024-03-30","2023-10-09",14,[91,92],"Depressive Disorder","Depression, Unipolar",[39],{"trials":95,"activeCount":52},[],{"trials":97,"activeCount":52},[],{"trials":99,"activeCount":52},[],{"intervention":101,"totalTrials":33,"cells":102},"Chlorhexidine gluconate",{"EARLY_PHASE1":103,"PHASE1":105,"PHASE2":107,"PHASE3":126,"PHASE4":128,"NA":130},{"trials":104,"activeCount":52},[],{"trials":106,"activeCount":52},[],{"trials":108,"activeCount":52},[109,118],{"nctId":110,"briefTitle":111,"status":58,"phases":112,"primaryCompletion":113,"completion":113,"start":114,"enrollment":115,"conditions":116,"interventions":117},"NCT02605382","Efficacy of 0.12% Chlorhexidine Gluconate for Peri-implant Mucositis",[43],"2013-12","2012-10",37,[25],[101],{"nctId":119,"briefTitle":120,"status":58,"phases":121,"primaryCompletion":113,"completion":113,"start":114,"enrollment":122,"conditions":123,"interventions":125},"NCT02639377","Efficacy of 0.12% Chlorhexidine Gluconate for Peri-implant Mucositis and Gingivitis",[43],29,[25,124],"Gingivitis",[101],{"trials":127,"activeCount":52},[],{"trials":129,"activeCount":52},[],{"trials":131,"activeCount":52},[],{"intervention":133,"totalTrials":9,"cells":134},"Ayahuasca",{"EARLY_PHASE1":135,"PHASE1":137,"PHASE2":139,"PHASE3":150,"PHASE4":152,"NA":154},{"trials":136,"activeCount":52},[],{"trials":138,"activeCount":52},[],{"trials":140,"activeCount":52},[141],{"nctId":142,"briefTitle":143,"status":58,"phases":144,"primaryCompletion":145,"completion":145,"start":146,"enrollment":147,"conditions":148,"interventions":149},"NCT02914769","Antidepressant Effects of Ayahuasca: a Randomized Placebo Controlled Trial in Treatment Resistant Depression",[42,43],"2016-12","2014-02",35,[78],[133],{"trials":151,"activeCount":52},[],{"trials":153,"activeCount":52},[],{"trials":155,"activeCount":52},[],{"intervention":157,"totalTrials":9,"cells":158},"salbutamol sulfate and ipratropium bromide",{"EARLY_PHASE1":159,"PHASE1":161,"PHASE2":163,"PHASE3":165,"PHASE4":167,"NA":169},{"trials":160,"activeCount":52},[],{"trials":162,"activeCount":52},[],{"trials":164,"activeCount":52},[],{"trials":166,"activeCount":52},[],{"trials":168,"activeCount":52},[],{"trials":170,"activeCount":52},[171],{"nctId":172,"briefTitle":173,"status":174,"phases":175,"primaryCompletion":176,"completion":177,"start":178,"enrollment":179,"conditions":180,"interventions":182},"NCT03271905","Influence of Mechanical Ventilation Modes on the Efficacy of Nebulized Bronchodilator","UNKNOWN",[46],"2018-12-10","2019-12-10","2017-04-10",10,[181,20],"COPD",[157]]